Clinical Trials | October 09, 2022
Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial
Study achieves primary endpoint of radiographic progression-free survival
Study achieves primary endpoint of radiographic progression-free survival
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
Subscribe To Our Newsletter & Stay Updated
